Thymosin α1: a single drug with multiple targets in cystic fibrosis
Nature Medicine 23, 536 (2017).
doi:10.1038/nm.4339
Authors: André M Cantin & John W Hanrahan
A new study in mice suggests that a single drug, thymosin α1, may simultaneously rectify the impaired trafficking of the cystic fibrosis transmembrane conductance regulator (CFTR) in cystic fibrosis (CF) and reduce inflammation, offering new hope for CF treatment.
Source: Nature Medicine - Category: Journals (General) Authors: Andr é M Cantin John W Hanrahan Tags: News and Views Source Type: research